Athira Pharma, Inc. (NASDAQ:LONA) Receives $17.33 Consensus Price Target from Brokerages
The Cerbat Gem
I'LL Inc. Delivers Double-Digit Profit Growth and Boosts Dividends Despite Lower 2027 Margin Outlook
TipRanks


